EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management

Liqin Ke, Lijun Guan, Yiyao Bao iD, Chao Tang iD

Genes · 27.06.2026 · 17 (7) · 743

DOI: 10.3390/genes17070743 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 27.06.2026. Verfasst von Liqin Ke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Han…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disorder caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It is increasingly understood through a genomics-informed framework linking variant architecture to phenotype, diagnosis, and therapeutic eligibility. This review summarizes current evidence on CFTR structure, variant interpretation, genotype-phenotype heterogeneity, diagnostic workflows, and modern management. We highlight how full-gene sequencing, curated disease-liability databases, functional testing, and organoid-informed theratyping refine diagnosis and treatment selection; how disrupted chloride and bicarbonate transport drives muco-obstructive airway disease and multisystem complications; and why modulator therapy must still be integrated with respiratory, nutritional, endocrine, hepatobiliary, reproductive, and psychosocial care. We also outline unresolved challenges in rare variants, residual organ damage, ancestry-related diagnostic gaps, and mutation-agnostic therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansMutationPhenotype

Stichwörter der Autor:innen

CFTRCFTR modulatorscystic fibrosisgenomic diagnosticsgenotype–phenotype correlationprecision medicinevariant interpretation

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou 310052, China.

ORCID-Profile: Yiyao Bao, Chao Tang

Zitieren

APA

Ke, L., Guan, L., Bao, Y., & Tang, C. (2026). Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management. Genes, 17(7), 743. https://doi.org/10.3390/genes17070743

Vancouver

Ke L, Guan L, Bao Y, Tang C. Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management. Genes. 2026;17(7):743. doi:10.3390/genes17070743

BibTeX
@article{Ke2026,
  author = {Ke, Liqin and Guan, Lijun and Bao, Yiyao and Tang, Chao},
  title = {Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {743},
  doi = {10.3390/genes17070743}
}
Kostenlos starten →